Hyderabad, India — September 6, 2024
Artixio proudly announces Femicura Healthtech as the recipient of the prestigious GEMi (Grant for Early-Stage Medtech Innovations). The GEMi grant, launched earlier this year by Artixio, aims to propel early-stage medtech startups toward impactful solutions that address critical health challenges.
About GEMi: Fueling Medtech Innovation
The GEMi grant was conceived with a clear mission: to foster groundbreaking advancements in medical technology. Artixio invited applications from visionary startups committed to developing prototypes that could revolutionize healthcare. With a focus on solving pressing health issues, the grant sought to empower innovators who dared to dream big.
Femicura Healthtech: Pioneering Women’s Health Diagnostics
From a competitive pool of 15+ applicants, Femicura Healthtech emerged as the standout choice. Their cutting-edge diagnostic technologies specifically target women’s health concerns, addressing unmet needs in this critical domain. By combining scientific rigor with a deep understanding of patient experiences, Femicura has created solutions that promise to transform lives.
Meena Udayasankar, Founder of Femicura Healthtech, Shares Her Vision:
“We are thrilled to receive the GEMi grant from Artixio. This recognition validates our commitment to advancing women’s health through innovative diagnostics. With Artixio’s support, we can accelerate the development of our groundbreaking prototypes and bring them closer to patients.”
Artixio’s Commitment to Medtech Advancement
Yogi Raj, Managing Director at Artixio, expressed enthusiasm about the initiative: “Our goal is to catalyze progress in healthcare by encouraging early-stage innovators. Femicura’s dedication to women’s health aligns perfectly with our mission. We believe that their technologies have the potential to make a lasting impact, and we’re excited to be part of their journey.”
About Artixio
Artixio is a global regulatory, quality, pharmacovigilance and market access consulting company supporting pharmaceutical and medical devices industry. With a commitment to innovation, Artixio continues to shape the future of healthcare.
Comments